Optimized mRNA encoding CAS9 for use in LNPs
US-12263227-B2 · Apr 1, 2025 · US
This page is not indexed by search engines while we improve data quality.
Wang Kui patents
Wang Kui is listed as an inventor on 8 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Wang Kui |
| Total patents | 8 |
| First publication | Mar 12, 2020 |
| Latest publication | Apr 1, 2025 |
Notable patents
Publications ranked by popularity score, then publication date.
Iron oxide nanoparticle-mediated radiation delivery for targeted cancer treatment
US-2025049843-A1 · Feb 13, 2025 · US
Iron oxide nanoparticle for suppressing drug-resistant gene for the treatment of glioblastoma
US-2023405145-A1 · Dec 21, 2023 · US
Polymeric carriers and methods
US-11560545-B2 · Jan 24, 2023 · US
Polymeric Carriers and Methods
US-2022403329-A1 · Dec 22, 2022 · US
Mrna large scale synthesis and purification
US-2022364078-A1 · Nov 17, 2022 · US
OPTIMIZED mRNA ENCODING CAS9 FOR USE IN LNPs
US-2022047723-A1 · Feb 17, 2022 · US
Polymeric Carriers and Methods
US-2020080051-A1 · Mar 12, 2020 · US
Recent patents
Latest publications not already listed above.
No data yet.
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Brigham & Womens Hospital Inc | 3 |
| Lonza Walkersville Inc | 3 |
| Massachusetts Inst Technology | 3 |
| Crispr Therapeutics Ag | 3 |
| Bayer Healthcare Llc | 3 |
Top CPC classifications
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C08L5/08 | 3 |
| C08L5/04 | 3 |
| C12N2533/40 | 3 |
| C12N2537/10 | 3 |
| C08L2312/00 | 3 |